Walleye Capital
DMIIU

Walleye Capital’s Drugs Made In America Acquisition II Corp Unit DMIIU Stock Holding History

Walleye Capital’s Portfolio DMIIU Stock Details DMIIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Hold
100,000
– – ﹤0.01% 2108
2026
Q1 		$1M Hold
100,000
– – ﹤0.01% 2070
2025
Q4 		$1M Hold
100,000
– – ﹤0.01% 2431
2025
Q3 		$995K Buy
+100,000
New +$997K ﹤0.01% 2104

Other funds holding DMIIU

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Walleye Capital's DMIIU Position: Q2 2026 in Review

Walleye Capital held its Drugs Made In America Acquisition II Corp Unit (DMIIU) position steady in Q2 2026 at 100,000 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2108.

Walleye Capital first reported a position in DMIIU in Q3 2025 and has held it in 4 quarters since. 11 funds tracked by Wall St. Rank hold DMIIU as of Q2 2026.

  • Walleye Capital held 100,000 shares of Drugs Made In America Acquisition II Corp Unit worth $1.02M as of Q2 2026.
  • Walleye Capital left its Drugs Made In America Acquisition II Corp Unit share count unchanged in Q2 2026.
  • Drugs Made In America Acquisition II Corp Unit made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2108 holding.
  • Walleye Capital first reported a position in Drugs Made In America Acquisition II Corp Unit in Q3 2025 and has held it in 4 quarters since.
  • 11 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Unit as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.